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 INTRODUCTION 
 Decision making has been defi ned as the process through 
which a person forms preferences, selects and executes ac-
tions, and evaluates the outcome related to a selected choice 
(Ernst & Paulus,  2005 ). In the last decade, there has been a 
growing interest to investigate the neural correlates of deci-
sion making in both healthy populations and brain-injured 
patients using neuropsychological and neuroimaging tech-
niques. In the somatic marker hypothesis, Damasio ( 1994) 
proposed that affective reactions induced by specifi c envi-
ronmental events provide a substrate for guiding decision by 
signals to a large subcortical frontal network including the 
amygdala and the ventromedial prefrontal cortex. Converg-
ing evidences suggest that decision making is not mediated 
by the orbitofrontal cortex alone, but relies on a larger dis-
tributed network (Bechara,  2001 ; Bechara et al.,  2000 ). 
 Given that multiple sclerosis (MS) is a disseminated pro-
cess affecting primarily the white matter of the central ner-
vous system, we hypothesized that this disease may infl uence 
decision making towards a more risky behavior. Using the 
Iowa Gambling Task (IGT) (Bechara et al.,  1994 ), we were 
able to demonstrate that patients with relapsing-remitting 
(RR) and secondary progressive (SP) MS exhibited impaired 
decision making and that these impaired decisions were as-
sociated with a decreased emotional experience as measured 
by the skin conductance response (Kleeberg et al.,  2004 ). 
Our data were confi rmed by Nagy et al. ( 2006) and Roca 
et al. ( 2008) who assessed decision making using the IGT in 
two groups of RRMS patients with mild disability and a 
short disease duration and found that an altered decisional 
process was at play even in early MS. However, there has 
been to date no longitudinal study of decision making in MS 
patients. Since even in its early stages MS is characterized 
by an axonal loss (Pascual et al.,  2007 ), we hypothesized 
that there would be a decline in decision-making perfor-
mances with time in RRMS. 
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 Abstract 
 The purpose of this study was to evaluate longitudinally, using the Iowa Gambling Task (IGT), the dynamics of 
decision-making capacity at a two-year interval (median: 2.1 years) in a group of patients with multiple sclerosis (MS) 
( n = 70) and minor neurological disability [Expanded Disability Status Scale (EDSS)  ≤ 2.5 at baseline]. Cognition 
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Results showed that IGT performances decreased from baseline to retest (from 0.3,  SD = 0.4 to 0.1,  SD = 0.3,  p = .005). 
MS patients who worsened in the IGT were more likely to show a decreased perceived health status and emotional 
well-being (SEP-59;  p = .05 for both). Relapsing rate, disability progression, cognitive, and behavioral changes were 
not associated with decreased IGT performances. In conclusion, decline in decision making can appear as an isolated 
defi cit in MS. ( JINS , 2009,  15 , 291–295 .) 
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 The present work was thus aimed at evaluating the dy-
namics of decision-making capacity at a two-year interval in 
a homogeneous group of RRMS patients with minor neuro-
logical defi cits. Cognition, behavior, mood, fatigue, and 
clinical parameters refl ecting MS activity and severity were 
examined in parallel. 
 METHODS 
 Participants 
 One hundred and twenty-eight patients with possible ( n = 38) 
or defi nite ( n = 90) MS according to McDonald diagnostic 
criteria (McDonald et al.,  2001 ; Polman et al.,  2005 ), with a 
RR course and a mild disability [Expanded Disability Status 
Scale (EDSS)  ≤ 2.5; Kurtzke,  1983 ] underwent the IGT and 
a neuropsychological testing between February 2004 and 
September 2005 (Simioni et al.,  2007 ; Souza Lima et al., 
 2007 ). A retest IGT evaluation was planned after a minimal 
period of 2 years, dated from baseline assessment. Only pa-
tients with confi rmed MS ( n = 70) were retested, including 
51 who already had defi nite MS at inclusion and 19 patients 
who had confi rmed MS diagnosis since baseline. Nineteen 
patients who did not confi rm MS diagnosis were excluded 
from retest, whereas 39 patients with confi rmed MS could 
not participate (18 did not accept to be retested and 21 were 
not able to be retested within the period of time fi xed for this 
study). Along with the IGT testing, neurological defi cits 
were scored using the EDSS, and the administered medica-
tions recorded. Patients presenting relapses between  baseline 
and retest were evaluated by two of the coauthors. Relapsing 
rate (number of relapses/year of study) and disability pro-
gression (change in the EDSS score/year of study) were cal-
culated. The complete testing was performed at least six 
weeks from a relapse or a corticosteroid treatment. All pa-
tients included had previously signed an informed consent 
form approved by the university Ethics Committee accord-
ing to the Declaration of Helsinki (1961). 
 Procedure 
 Cognitive and behavioral assessment 
 The screening neuropsychological evaluation, performed at 
baseline and at retest, has been described elsewhere (Simioni 
et al.,  2007 ; Souza Lima et al.,  2007 ). We used the Rey’s Audi-
tory Verbal Learning Test (RAVLT) to assess long-term mem-
ory, the Trail Making Test (TMT) for attention/processing 
speed, and the Behavioral Assessment of the Dysexecutive 
Syndrome (BADS) for executive functions because it was vali-
dated on a large group of patients with various neurological 
disorders, including MS. Alternate versions of the tests were 
used at retest for the RAVLT and the TMT to minimize practice 
effect. Cognitive impairment was defi ned as a performance two 
standard deviations ( SD ) below the given mean in at least one 
of the three cognitive measures, whereas cognitive decline was 
defi ned as a change in cognitive status from baseline to retest. 
 Questionnaires measuring dysexecutive behaviors [Dys-
executive Questionnaire (DEX)] and behavioral modifi ca-
tions between baseline and retest [Iowa Scale of Personality 
Change (ISPC)] were completed by a relative. Fatigue 
 [Fatigue Assessment Instrument (FAI)], mood disorders 
[Hospital Anxiety and Depression scale (HAD)], handicap 
[London Handicap Scale (LHS)], and perceived health status 
(SEP-59) were assessed using self-reported questionnaires. 
 Iowa Gambling Task (IGT) 
 Decision making was tested at baseline using the origi-
nal computerized version of the IGT (Version ABCD), and 
retested at follow-up with a parallel version of the task 
 (Version KLMN). This latter version, recently validated by 
Hernandez et al. ( 2006) , was constructed with different win 
and loss values to be administered after the ABCD version. 
Decks A/B at baseline and L/N at retest were associated with 
high immediate wins, but even higher future losses, ending 
in a long-term loss (disadvantageous decks). To the opposite, 
decks C/D at baseline and K/M at retest were associated with 
low immediate wins, but even lower future losses, resulting 
in a long-term gain (advantageous decks). The total number 
of advantageous decks selected per block of 20 cards was 
computed [(C + D or K + M) – (A + B or L + N)]. Net scores 
below ( vs. above) zero indicated that patients were choosing 
disadvantageously ( vs. advantageously). A learning index, 
measuring how patients evolved from disadvantageous to 
advantageous decks, was defi ned as the difference between 
the averaged last three and fi rst two block rates ([(B3 + B4 + 
B5)/3] – [(B1 + B2)/2]). 
 Statistical Analyses 
 Statistical analyses were conducted using a STATA software 
package (Version 10.0). The IGT learning index, DEX, ISPC, 
LHS, and SEP-59 scores, as well as the proportion of patients 
with cognitive defi cits, anxious (HAD-Anxiety), depressive 
(HAD-Depression) or fatigue symptoms were computed at 
baseline and retest. A standardized change score [(score at 
 retest – score at baseline)/standard deviation of baseline score] 
was calculated for scores expressed in a numerical scale. The 
hypothesis of an absence of change was tested using nonpara-
metric tests (Wilcoxon or MacNemar tests) since we had no 
 a priori on the Gaussian distribution of the scores and data 
presented with a few outliers. Signifi cance was set at  p < .05 
for all statistics. As analyses involved nine measures, a 
 Bonferroni corrected standard  p level of  p < .006 was applied. 
 Subsequently, standardized change scores were dichoto-
mized and a score  ≥ 0.5 towards worsening was defi ned as a 
threshold for a decline in performance. Patients who de-
clined in the IGT learning index were compared with those 
who did not for their relapsing rate, disability progression, 
concomitant decline in cognition, and for DEX, ISPC, LHS, 
or SEP-59 scores (Fisher exact tests). A logistic regression 
approach was used to look for potential baseline predictors 
for a decline in decision making. 
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 To control for a possible sampling bias in interpreting our 
results due to 33% missing questionnaires at retest, we eval-
uated whether a missing response to a questionnaire at retest 
( n = 22 to 27, depending on the scale) was associated with 
the score obtained for this questionnaire at baseline. Finally, 
we compared the baseline neurological and neuropsycho-
logical characteristics of the 39 confi rmed MS patients who 
could not be retested with those of the 70 retested patients. 
 RESULTS 
 Demographic and Neurological Characteristics 
of the Patients 
 The 70 patients with defi nite MS (50 women and 20 men) 
with a median age of 35 years (range 19 to 62 years) were 
tested twice for the IGT with a median interval of 2.1 years 
(range 2 to 2.6 years) between baseline and retest. Of those, 
60 patients (86%) had at least secondary education. Sixty-
eight patients had a proven RRMS course at retest according 
to McDonald criteria (McDonald et al.,  2001 ; Polman et al., 
 2005 ) while two patients had converted to SPMS since base-
line. At retest, the median MS duration was 4 years (range 
2.4 to 8.5 years), the median EDSS score was 2.0 (range 1.5 
to 3.5), and 35 MS patients had experienced one to fi ve re-
lapses since baseline (median number of relapses during the 
study: 0.5). The median relapsing rate (number of relapses/
year of study) was of 0.2 (range: 0 to 2.4). Overall, no pro-
gression in disability rate was observed [median change in 
the EDSS score/year of study: 0 (range: –0.3 to 0.7)]. Forty-
nine patients were treated with interferon- β 1a or 1b at retest, 
including 20 newly treated patients since baseline. Nine 
patients had antidepressants at retest  versus three at baseline, 
and four had amantadine or modafi nil as a symptomatic treat-
 ment for fatigue  versus two at baseline. 
 Evolution of Cognitive, Behavioral, and 
Functional Scores 
 Results obtained for the cognitive and behavioral functions are 
presented in  Table 1 . All data were available for the 70 MS pa-
tients, except for some missing behavioral questionnaires com-
pleted at home (22 were not sent back, 5 had missing values). 
Between baseline and retest, the prevalence of cognitive defi cits 
increased slightly from 30% to 40%, without reaching signifi -
cance ( p = .1). Specifi cally, the prevalence of defi cits in attention 
increased from 9 to 29% ( p = .002), whereas it remained un-
changed for long-term memory and executive tasks. Concerning 
behavioral data, anxious symptoms (HAD-Anxiety) were mar-
ginally less frequently reported at retest (49% at baseline  vs. 
32% at retest;  p = .08). No other changes were observed. 
 Changes in IGT Performances 
 The learning index decreased from baseline to retest [from 
0.3 ( SD 0.4) to 0.1 ( SD 0.3),  p = .005] ( Table 1 ). This result 
remained signifi cant after Bonferroni correction. 
 Variables Associated with a Decreased 
Learning Index 
 We compared MS patients who declined in the IGT ( n = 31) 
with patients who did not ( n = 39) on relapsing rate,  disability 
progression, cognitive performances, DEX, ISPC, LHS, and 
 Table 1.(A)  Mean scores of the multiple sclerosis (MS) patients for the IGT, behavioral questionnaires, handicap, and perceived health 
status evaluated at baseline and retest; (B) Number (%) of patients with cognitive impairment, mood disorders, or fatigue at baseline and 
retest, as well as number (%) of patients who declined (Delta +) or improved (Delta –) between the two evaluations. 
 (A)  
 Measures  N  Baseline  Retest  Change score  p -values * 
 IGT (learning index), mean ±  SD  70  0.3 ± 0.4  0.1 ± 0.3  –0.5 ± 1.3  .005 
 DEX, mean ± SD ***  43  17.4 ± 10.3  18.3 ± 11.7  0.1 ± 0.6  .5 
 ISPC (post-morbid score), mean ±  SD ***  45  83.9 ± 18.7  79.9 ± 22.7  −0.2 ± 1.0  .2 
 Total LHS score, mean ±  SD ***  47  8.8 ± 3.0  9.2 ± 3.8  0.2 ± 0.8  .1 
 Total SEP-59 score, mean ±  SD ***  46  46.0 ± 11.7  46.3 ± 12.7  0.03 ± 0.8  .8 
 (B)  
 Measures  N  Baseline  Retest  Delta +  Delta –  p -values ** 
 Overall cognitive impairment,  n (%)  70  21 (30)  28 (40)  12 (17)  5 (7)  .1 
 Memory defi cits,  n (%)  70  15 (21)  15 (21)  8 (11)  8 (11)  1.0 
 Attention defi cits,  n (%)  70  6 (9)  20 (29)  17 (24)  3 (4)  .002 
 Executive dysfunction,  n (%)  70  3 (4)  4 (6)  4 (6)  3 (4)  .7 
 HAD-Anxiety,  n (%) ***  47  23 (49)  15 (32)  4 (8)  12 (25)  .08 
 HAD-Depression,  n (%) ***  47  9 (19)  4 (8)  2 (4)  7 (15)  .2 
 FAI-Severity,  n (%) ***  45  21 (47)  19 (42)  4 (9)  6 (13)  .8 
 Note. IGT = Iowa Gambling Task, DEX = Dysexecutive Questionnaire, ISPC = Iowa Scale of Personality Change, LHS = London Handicap Scale, SEP-59 = 
perceived health status, HAD = Hospital Anxiety and Depression scales, FAI = Fatigue Assessment Instrument. *Wilcoxon signed rank test, **McNemar 
test, ***22 to 27 questionnaires were either not sent back by the patients or not fully completed. 
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SEP-59 scores ( Table 2 ). MS patients who declined in the 
IGT were more likely to show a decline in the SEP-59 total 
score ( p = .05) and in the SEP-59 emotional well-being sub-
scale ( p = .05). No other differences emerged. These results 
were not modifi ed when using an analysis of covariance 
(ANCOVA) model taking the IGT standardized change score 
as a continuous dependent variable and the other standard-
ized change scores as continuous independent variables. 
 Adjusting for HAD-Anxiety, HAD-Depression, and FAI-
Severity scores did not change the results (data not shown). 
 Baseline Predictors of a Decline in IGT 
Performance 
 Odds ratio of a decline in the IGT was 0.75 [95% Confi dence 
Interval (CI), 0.3–1.8] for a unit increase in relapsing rate 
and 0.14 (95% CI, 0.01–1.5) for disability progression. None 
of the potential baseline predictors (cognitive status, DEX, 
ISPC, LHS, SEP-59 scores) was associated with a decline 
in the IGT performance, except for the baseline IGT score 
itself ( p < .0001). 
 Analysis of the Patients with Missing Data 
 No signifi cant difference emerged between the 39 confi rmed 
MS patients who could not be retested (see Methods) and the 
70 patients who completed the retest examination in their 
demographic, neurological, cognitive, and behavioral fea-
tures at baseline. Besides, missing data to a given question-
naire at retest was not associated with the score obtained for 
this given questionnaire at baseline (data not shown). 
 DISCUSSION 
 We found a signifi cant decrease in the IGT performance over 
time in a group of RRMS patients with mild disability and 
short disease duration. Such a worsening in the IGT perfor-
mance with the alternate version of the task is unexpected in 
a control population, as recently demonstrated by Hernandez 
et al. ( 2006) . By analyzing MS patients who participated to 
baseline assessment but did not undergo retest, we further 
ensured that our results were only minimally biased by miss-
ing values. 
 The IGT has been used to measure decision making under 
ambiguity (in contrast with decision making under certainty 
where the outcome is surely defi ned) in different neurologi-
cal conditions. To solve the task successfully, subjects have 
to fi gure out advantageous decks by using the feedback they 
get after each choice and by following their own feelings 
and hunches, according to the somatic marker hypothesis of 
Damasio ( 1994) . Emotional reactions secondary to the out-
comes of previous choices infl uence decisions on successive 
choices, meaning that subjects become more cautious and 
aversive to risk taking. Emotions are thus thought to serve an 
adaptive role speeding up the decisional process. Studying 
a group of MS patients more disabled than in the present 
work, we reported that an impairment in the emotional di-
mension of behavior (DEX) or in emotional experience was 
associated with risky decision making (Kleeberg et al., 
 2004 ). Here, testing mild MS patients, we could not fi nd a 
signifi cant link between a decline in decision making and 
affective measures (HAD, DEX). However, such a result 
should be interpreted with caution, as it might be a result of 
lack of statistical power (missing values in the behavioral 
questionnaires). Yet, a decrease in a health status index of 
emotion (SEP-59 emotional well-being subscale) was mar-
ginally associated with a more risky behavior in the IGT. 
 Decline in decision making was independent of other neu-
rological, cognitive, or behavioral changes occurring during 
the same period of time. Such as Nagy et al. ( 2006) , we could 
not relate dysfunction in the IGT to executive defi cits or to 
general cognitive impairment. In addition, decline in IGT 
performances occurred independently of MS course (i.e., 
sustained progression in disability or relapsing rate during 
 Table 2.  Association of a decrease in decision-making ability with a change in neurological indices, cognitive, or behavioral scores 
between baseline and retest. 
 
 Patients remaining 
stable in the IGT ( n = 39) 
 Patients worsening 
in the IGT ( n = 31)  p -values 
 Neurological indices ( n = 70) 
 Disability progression, median (range)  0 (–0.2;0.7)  0 (–0.2;0.5)  .1 * 
 Relapsing rate, median (range)  0 (0;1.8)  0.4 (0;–2.4)  .5 * 
 Worsening cognitive and behavioral scores 
 Overall cognitive defi cits, n (%) ( n = 70)  7 (18)  5 (16)  1.0 ** 
 Memory defi cits,  n (%)  4 (10)  4 (13)  1.0 ** 
 Attention defi cits,  n (%)  10 (26)  7 (23)  1.0 ** 
 Executive dysfunction,  n (%)  1 (3)  3 (10)  .3 ** 
 DEX score,  n (%) ( n = 43)  5/22 (23)  4/21 (19)  1.0 ** 
 ISPC (post-morbid score),  n (%) ( n = 45)  2/23 (9)  4/22 (19)  .4 ** 
 Handicap (LHS) total score ( n = 47)  5/25 (20)  5/22 (23)  1.0 ** 
 Perceived health status (SEP-59) total score ( n = 46)  4/25 (16)  9/21 (43)  .05 ** 
 Note. IGT = Iowa Gambling Task, DEX = Dysexecutive Questionnaire, ISPC = Iowa Scale of Personality Change, LHS = London Handicap Scale, SEP-59 = 
perceived health status. *Wilcoxon signed rank test. **Fisher exact test. 
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the study period), giving weight to the hypothesis of Nagy 
et al. ( 2006) that decision-making diffi culties at an early 
stage of the MS process may refl ect subclinical pathology. In 
fact, our group remained mildly disabled throughout the 
study (EDSS score  ≤ 2.5) except for fi ve patients who had 
reached an EDSS score of 3.0 ( n = 4) or 3.5 ( n = 1) at retest. 
Although 35 MS patients (50%) experienced relapses be-
tween baseline and retest, these were rarely associated with a 
progression of disability. When occurring, changes in the 
EDSS score were mostly not clinically relevant (0.5 point 
increase) in such a mildly disabled population. 
 In conclusion, decline in decision-making capacity, espe-
cially under ambiguity, can appear as an isolated and earlier 
defi cit in MS as compared to other functions. Given the IGT 
unique contribution, it might be considered in addition to 
more traditional tests when evaluating MS patients. Yet, the 
potential factors affecting the decisional process remain a sub-
ject of debate. While statistically signifi cant, the IGT deterio-
ration was not associated with other markers of cognitive, 
emotional, or disability changes. Therefore, the true signifi -
cance of the IGT will await further investigation. Studies of 
neurological patients with decisional impairments showed 
that they are still able to make correct decisions in many situ-
ations, especially when the context is more certain. Thus, the 
study of other decisional processes in MS may be relevant. 
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